CD4 and Huntington disease: In addition to Tregs, the IL-2 receptor is also involved in the differentiation of anti-inflammatory Th2 cells, which have been reported to be diminished in HD patients and may be reflected in the significantly lower CD4+ proportions observed in our HD subjects at V1D7.